Pressure BioSciences Announces Approval to Manufacture Hemp-Derived CBD Products in Massachusetts, Including Their Revolutionary CBD Nanoemulsions
August 11, 2022
Health
-
-
NEXGEL Reports Second Quarter 2022 Financial Results
August 10, 2022
-
Endexx Mass Retail Reach in Three of Top 8 US Retailers
August 10, 2022
-
The Alkaline Water Company Completes Company-Wide Review and Identifies Approximately $15 Million in Cost Savings and Margin Enhancements
August 9, 2022
-
OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense
August 9, 2022
-
CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call
August 9, 2022
-
NeuroOne® Submits Special 510(k) to FDA for Evo® sEEG Electrode
August 9, 2022
-
Curaleaf Announces Majority Stake and Forms Strategic Partnership with Germany’s Four 20 Pharma, a Fully EU-GMP & GDP Licensed Producer and Distributor of Medical Cannabis
August 9, 2022
-
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022
August 9, 2022
-
Augmedix Announces Expanded Partnership with Adventist Health
August 8, 2022
-
Curaleaf Reports Second Quarter 2022 Results
August 8, 2022
-
The Science of Better Pharmaceutical Delivery
August 8, 2022
-
SANUWAVE Closes $12 Million Capital Raise
August 8, 2022
-
SANUWAVE Appoints New Board Chairman
August 8, 2022
-
Curaleaf Bolsters Executive Leadership Team with Three Key Hires
August 8, 2022
-
Pressure BioSciences Doubles Growth Projections for UST Nanoemulsion Contracts Following Clear Confirmation of Unmet Needs in Exploding Cannabis Drinks Sector
August 5, 2022